U-Shaped Association of High-Density Lipoprotein Cholesterol with All-Cause and Cardiovascular Mortality in Hypertensive Population

References

• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e563–e595.30879339
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–2381.27222591
   PubMed Web of Science ®Google Scholar
• Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256(20):2835–2838. doi:10.1001/jama.1986.033802000730243773200
   PubMed Web of Science ®Google Scholar
• Penson P, Long DL, Howard G, et al. Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study. Cardiovasc Res. 2019;115(1):204–212. doi:10.1093/cvr/cvy19830576432
   PubMed Web of Science ®Google Scholar
• Okamura T, Hayakawa T, Kadowaki T, et al. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis. 2006;184(1):143–150. doi:10.1016/j.atherosclerosis.2005.03.04215913635
   PubMed Web of Science ®Google Scholar
• Saleheen D, Scott R, Javad S, et al. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol. 2015;3(7):507–513. doi:10.1016/S2213-8587(15)00126-626025389
   PubMed Web of Science ®Google Scholar
• Keene D, Price C, Shun-Shin MJ, et al. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 2014;349(jul18 2):g4379. doi:10.1136/bmj.g437925038074
   PubMed Web of Science ®Google Scholar
• Bowman L, Hopewell JC, Chen F, et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med. 2017;377:1217–1227.28847206
   PubMed Web of Science ®Google Scholar
• Di Bartolo BA, Duong M, Nicholls SJ. Clinical trials with cholesteryl ester transfer protein inhibitors. Curr Opin Lipidol. 2016;27(6):545–549. doi:10.1097/MOL.000000000000035227676199
   PubMed Web of Science ®Google Scholar
• Kingwell BA, Chapman MJ, Kontush A, et al. HDL-targeted therapies: progress, failures and future. Nat Rev Drug Discov. 2014;13:445–464.24854407
   PubMed Web of Science ®Google Scholar
• Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384(9943):618–625. doi:10.1016/S0140-6736(14)61217-425131981
   PubMed Web of Science ®Google Scholar
• Angeloni E, Paneni F, Landmesser U, et al. Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting. Eur Heart J. 2013;34(46):3557–3562. doi:10.1093/eurheartj/eht16323704708
   PubMed Web of Science ®Google Scholar
• Silbernagel G, Schöttker B, Appelbaum S, et al. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J. 2013;34(46):3563–3571. doi:10.1093/eurheartj/eht34324014391
   PubMed Web of Science ®Google Scholar
• Hirata A, Okamura T, Sugiyama D, et al. The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population. J Atheroscler Thromb. 2016;23(7):800–809. doi:10.5551/jat.3344926923252
   PubMed Web of Science ®Google Scholar
• Zhong GC, Huang SQ, Peng Y, et al. HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies. Eur J Prev Cardiol. 2020;2047487320914756.
   Web of Science ®Google Scholar
• Oh IH, Hur JK, Ryoo JH, et al. Very high high-density lipoprotein cholesterol is associated with increased all-cause mortality in South Koreans. Atherosclerosis. 2019;283:43–51. doi:10.1016/j.atherosclerosis.2019.01.03530776703
   PubMed Web of Science ®Google Scholar
• Li X, Guan B, Wang Y, et al. Association between high-density lipoprotein cholesterol and all-cause mortality in the general population of northern China. Sci Rep. 2019;9(1):14426. doi:10.1038/s41598-019-50924-431594968
   PubMed Web of Science ®Google Scholar
• Hamer M, O’Donovan G, Stamatakis E. High-Density Lipoprotein Cholesterol and Mortality: too Much of a Good Thing? Arterioscler Thromb Vasc Biol. 2018;38(3):669–672. doi:10.1161/ATVBAHA.117.31058729326314
   PubMed Web of Science ®Google Scholar
• Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38(32):2478–2486. doi:10.1093/eurheartj/ehx16328419274
   PubMed Web of Science ®Google Scholar
• Yu S, Guo X, Li GX, et al. Lower or higher HDL-C levels are associated with cardiovascular events in the general population in rural China. Lipids Health Dis. 2020;19(1):152. doi:10.1186/s12944-020-01331-632586331
   PubMed Web of Science ®Google Scholar
• Sharif S, van der Graaf Y, Nathoe HM, et al. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care. 2016;39(8):1424–1430. doi:10.2337/dc16-015527222511
   PubMed Web of Science ®Google Scholar
• Harari G, Green MS, Magid A, et al. Usefulness of Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality in Men in 22-Year Follow-Up. Am J Cardiol. 2017;119(8):1193–1198. doi:10.1016/j.amjcard.2017.01.00828267961
   PubMed Web of Science ®Google Scholar
• Sung KC, Ryu S, Wild SH, et al. An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality. Heart. 2015;101(7):553–558. doi:10.1136/heartjnl-2014-30678425637367
   PubMed Web of Science ®Google Scholar
• Doran B, Guo Y, Xu J, et al. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III). Circulation. 2014;130(7):546–553. doi:10.1161/CIRCULATIONAHA.114.01000125015340
   PubMed Web of Science ®Google Scholar
• Bucholz EM, Rodday AM, Kolor K, et al. Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999–2014). Circulation. 2018;137(21):2218–2230. doi:10.1161/CIRCULATIONAHA.117.03232129581125
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. doi:10.1093/clinchem/18.6.4994337382
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.11904577
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–520. doi:10.1001/jama.2013.28442724352797
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. 2. Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement 1):S14–S31. doi:10.2337/dc20-S00231862745
   PubMed Web of Science ®Google Scholar
• Mazidi M, Mikhailidis DP, Banach M. Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults. Int J Cardiol. 2019;276:242–247. doi:10.1016/j.ijcard.2018.11.09530473336
   PubMed Web of Science ®Google Scholar
• Li ZH, Lv YB, Zhong WF, et al. High-Density Lipoprotein Cholesterol and All-Cause and Cause-Specific Mortality Among the Elderly. J Clin Endocrinol Metab. 2019;104(8):3370–3378. doi:10.1210/jc.2018-0251130869791
   PubMed Web of Science ®Google Scholar
• Navaneethan SD, Schold JD, Walther CP, et al. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018;12(4):1061–1071.e1067. doi:10.1016/j.jacl.2018.03.08529699917
   PubMed Web of Science ®Google Scholar
• Bowe B, Xie Y, Xian H, et al. High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans. Clin J Am Soc Nephrol. 2016;11(10):1784–1793. doi:10.2215/CJN.0073011627515591
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Ye X, Raimann JG, et al. Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results. J Lipid Res. 2018;59:1519–1528.29895699
   PubMed Web of Science ®Google Scholar
• Ko DT, Alter DA, Guo H, et al. High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: the CANHEART Study. J Am Coll Cardiol. 2016;68(19):2073–2083. doi:10.1016/j.jacc.2016.08.03827810046
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–3104.30165516
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248.29146535
   PubMed Web of Science ®Google Scholar
• Frikke-Schmidt R. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population. Atherosclerosis. 2010;208(2):305–316. doi:10.1016/j.atherosclerosis.2009.06.00519596329
   PubMed Web of Science ®Google Scholar
• Genga KR, Trinder M, Kong HJ, et al. CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsis. Sci Rep. 2018;8(1):16764. doi:10.1038/s41598-018-35261-230425299
   PubMed Web of Science ®Google Scholar
• Zanoni P, Khetarpal SA, Larach DB, et al. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science. 2016;351(6278):1166–1171. doi:10.1126/science.aad351726965621
   PubMed Web of Science ®Google Scholar
• Zh L, Yb L, Wf Z, et al. High-density lipoprotein cholesterol and all-cause and cause-specific mortality among the elderly. Sci Rep. 2019;104:3370–3378.
   Google Scholar
• Huang CY, Lin FY, Shih CM, et al. Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways. Arterioscler Thromb Vasc Biol. 2012;32(10):2405–2417. doi:10.1161/ATVBAHA.112.24861722904272
   PubMed Web of Science ®Google Scholar
• Otocka-Kmiecik A, Mikhailidis DP, Nicholls SJ, et al. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid Res. 2012;51(4):314–324. doi:10.1016/j.plipres.2012.03.00322609245
   PubMed Web of Science ®Google Scholar